Found: 7
Select item for more details and to access through your institution.
Extracellular Vesicles as Biomarkers in Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 16217, doi. 10.3390/ijms232416217
- By:
- Publication type:
- Article
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11840, doi. 10.3390/ijms231911840
- By:
- Publication type:
- Article
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
- Published in:
- Liver International, 2023, v. 43, n. 9, p. 1909, doi. 10.1111/liv.15604
- By:
- Publication type:
- Article
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1410, doi. 10.1111/liv.15230
- By:
- Publication type:
- Article
Emerging pharmacological treatment options for MAFLD.
- Published in:
- Therapeutic Advances in Endocrinology & Metabolism, 2022, p. 1, doi. 10.1177/20420188221142452
- By:
- Publication type:
- Article
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06614-9
- By:
- Publication type:
- Article
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD.
- Published in:
- 2022
- By:
- Publication type:
- journal article